Literature DB >> 14774471

Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.

R W RUNDLES, M L DILLON, E S DILLON.   

Abstract

Entities:  

Keywords:  TUMORS, MULTIPLE MYELOMA; URETHANE; URINE

Mesh：

Substances：

Year:  1950        PMID： 14774471      PMCID： PMC436167          DOI： 10.1172/JCI102362

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease.

Authors:  C E Dent; G A Rose
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

2.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

3.  Immunological differences of crystalline Bence-Jones proteins.

Authors:  L Hektoen; W H Welker
Journal:  Biochem J       Date:  1940-04       Impact factor: 3.857

4.  An analysis of Bence-Jones protein.

Authors:  J Devine
Journal:  Biochem J       Date:  1941-03       Impact factor: 3.857

5.  BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA.

Authors:  D H Moore; E A Kabat; A B Gutman
Journal:  J Clin Invest       Date:  1943-01       Impact factor: 14.808

6.  ON THE PATHOGENESIS OF RENAL FAILURE ASSOCIATED WITH MULTIPLE MYELOMA. ELECTROPHORETIC AND CHEMICAL ANALYSIS OF PROTEIN IN URINE AND BLOOD SERUM.

Authors:  S S Blackman; W H Barker; M V Buell; B D Davis
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

7.  FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA.

Authors:  A B Gutman; D H Moore; E B Gutman; V McClellan; E A Kabat
Journal:  J Clin Invest       Date:  1941-11       Impact factor: 14.808

8.  Streptomycin-sensitive, -dependent, and -resistant Bacteria.

Authors:  T F Paine; M Finland
Journal:  Science       Date:  1948-02-06       Impact factor: 47.728

9.  A study of renal function in patients with multiple myeloma.

Authors:  J B ARMSTRONG
Journal:  Am J Med Sci       Date:  1950-05       Impact factor: 2.378

10.  Studis on the Early Chang in the Livers of Rates Treated with Various Toxic Agents, with Especial Reference to the Vascular Lesions: I. The Histology of the Rat's Liver in Urethane Poisoning.

Authors:  L Doljanski; A Rosin
Journal:  Am J Pathol       Date:  1944-09       Impact factor: 4.307
View more
  9 in total

1.  MELPHALAN THERAPY IN MYELOMATOSIS.

Authors:  J WALDENSTROEM
Journal:  Br Med J       Date:  1964-04-04

2.  Multiple myeloma.

Authors:  W A SKOOG; W S ADAMS
Journal:  Calif Med       Date:  1963-08

3.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

4.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

5.  Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.

Authors:  R W RUNDLES; G R COOPER; R W WILLETT
Journal:  J Clin Invest       Date:  1951-10       Impact factor: 14.808

6.  The formation of myeloma protein by a mouse plasma cell tumor.

Authors:  D NATHANS; J L FAHEY; M POTTER
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

7.  The carbohydrate of gamma-globulin and myeloma proteins.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

8.  Criteria for the identification of homogenous electrophoretic peaks in multiple myeloma.

Authors:  H O CONN; G KLATSKIN
Journal:  Yale J Biol Med       Date:  1962-08

9.  Immunological relationships among the myeloma proteins.

Authors:  R J SLATER; S M WARD; H G KUNKEL
Journal:  J Exp Med       Date:  1955-01-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.